These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33068421)

  • 1. Associations of meningioma molecular subgroup and tumor recurrence.
    Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
    Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
    Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
    Youngblood MW; Duran D; Montejo JD; Li C; Omay SB; Özduman K; Sheth AH; Zhao AY; Tyrtova E; Miyagishima DF; Fomchenko EI; Hong CS; Clark VE; Riche M; Peyre M; Boetto J; Sohrabi S; Koljaka S; Baranoski JF; Knight J; Zhu H; Pamir MN; Avşar T; Kilic T; Schramm J; Timmer M; Goldbrunner R; Gong Y; Bayri Y; Amankulor N; Hamilton RL; Bilguvar K; Tikhonova I; Tomak PR; Huttner A; Simon M; Krischek B; Kalamarides M; Erson-Omay EZ; Moliterno J; Günel M
    J Neurosurg; 2020 Nov; 133(5):1345-1354. PubMed ID: 31653806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
    Olar A; Wani KM; Wilson CD; Zadeh G; DeMonte F; Jones DT; Pfister SM; Sulman EP; Aldape KD
    Acta Neuropathol; 2017 Mar; 133(3):431-444. PubMed ID: 28130639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
    Ren L; Xie Q; Deng J; Chen J; Yu J; Wang D; Wakimoto H; Gong Y; Hua L
    J Neurosurg; 2024 Sep; 141(3):593-601. PubMed ID: 38552238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
    Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
    J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.
    Ehret F; Perez E; Teichmann D; Meier S; Geiler C; Zeus C; Franke H; Roohani S; Wasilewski D; Onken J; Vajkoczy P; Schweizer L; Kaul D; Capper D
    Acta Neuropathol Commun; 2024 May; 12(1):74. PubMed ID: 38720399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
    Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A
    Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POLR2A Mutation is a Poor Prognostic Marker of Cerebellopontine Angle Meningioma.
    Okano A; Miyawaki S; Teranishi Y; Hongo H; Dofuku S; Ohara K; Sakai Y; Shin M; Nakatomi H; Saito N
    Neurosurgery; 2024 Aug; 95(2):275-283. PubMed ID: 38380947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
    Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
    J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.
    Jin L; Youngblood MW; Gupte TP; Vetsa S; Nadar A; Barak T; Yalcin K; Aguilera SM; Mishra-Gorur K; Blondin NA; Gorelick E; Omay SB; Pointdujour-Lim R; Judson BL; Alperovich M; Aboian MS; McGuone D; Gunel M; Erson-Omay Z; Fulbright RK; Moliterno J
    J Neurooncol; 2021 Sep; 154(2):237-246. PubMed ID: 34350560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.
    Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR
    Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.
    Collord G; Tarpey P; Kurbatova N; Martincorena I; Moran S; Castro M; Nagy T; Bignell G; Maura F; Young MD; Berna J; Tubio JMC; McMurran CE; Young AMH; Sanders M; Noorani I; Price SJ; Watts C; Leipnitz E; Kirsch M; Schackert G; Pearson D; Devadass A; Ram Z; Collins VP; Allinson K; Jenkinson MD; Zakaria R; Syed K; Hanemann CO; Dunn J; McDermott MW; Kirollos RW; Vassiliou GS; Esteller M; Behjati S; Brazma A; Santarius T; McDermott U
    Sci Rep; 2018 Sep; 8(1):13537. PubMed ID: 30202034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
    Peyre M; Gauchotte G; Giry M; Froehlich S; Pallud J; Graillon T; Bielle F; Cazals-Hatem D; Varlet P; Figarella-Branger D; Loiseau H; Kalamarides M
    Neuro Oncol; 2018 Jul; 20(8):1113-1121. PubMed ID: 29216385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.
    Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S
    Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
    Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
    J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific gene expression signatures of low grade meningiomas.
    Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF
    Front Oncol; 2023; 13():1126550. PubMed ID: 36937440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.